These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34512348)

  • 1. The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B.
    Jiang SL; Wang ZB; Zhu T; Jiang T; Fei JF; Liu C; Luo C; Cheng Y; Liu ZQ
    Front Pharmacol; 2021; 12():720619. PubMed ID: 34512348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHMFL-BMX-078, a BMX inhibitor, overcomes the resistance of melanoma to vemurafenib via inhibiting AKT pathway.
    Jiang S; Jiang T; Huang H; Chen X; Li L; Wang Z; Fei J; Liu C; Liu Z; Cheng Y
    Chem Biol Interact; 2022 Jan; 351():109747. PubMed ID: 34813779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespib.
    Acquaviva J; Smith DL; Jimenez JP; Zhang C; Sequeira M; He S; Sang J; Bates RC; Proia DA
    Mol Cancer Ther; 2014 Feb; 13(2):353-63. PubMed ID: 24398428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-204-5p and miR-211-5p Contribute to BRAF Inhibitor Resistance in Melanoma.
    Díaz-Martínez M; Benito-Jardón L; Alonso L; Koetz-Ploch L; Hernando E; Teixidó J
    Cancer Res; 2018 Feb; 78(4):1017-1030. PubMed ID: 29229605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
    Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
    Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting STAT3 restores BRAF inhibitor sensitivity through miR-759-3p in human cutaneous melanoma cells.
    Su Y; Yu Y; He D; Zhang J; Wang Z; Sun P; Chen Z
    Int J Clin Exp Pathol; 2018; 11(5):2550-2560. PubMed ID: 31938368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF
    Carpenter EL; Chagani S; Nelson D; Cassidy PB; Laws M; Ganguli-Indra G; Indra AK
    Mol Carcinog; 2019 Sep; 58(9):1680-1690. PubMed ID: 31211467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA sequencing data of Vemurafenib-resistant melanoma cells and parental cells.
    Zhao K; Lu Y; Chen Y; Cheng J; Zhang W
    Data Brief; 2020 Jun; 30():105610. PubMed ID: 32382617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
    Xiao J; Egger ME; McMasters KM; Hao H
    BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kulkarni A; Al-Hraishawi H; Simhadri S; Hirshfield KM; Chen S; Pine S; Jeyamohan C; Sokol L; Ali S; Teo ML; White E; Rodriguez-Rodriguez L; Mehnert JM; Ganesan S
    Clin Cancer Res; 2017 Sep; 23(18):5631-5638. PubMed ID: 28539463
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting CDC7 sensitizes resistance melanoma cells to BRAF
    Gad SA; Ali HEA; Gaballa R; Abdelsalam RM; Zerfaoui M; Ali HI; Salama SH; Kenawy SA; Kandil E; Abd Elmageed ZY
    Sci Rep; 2019 Oct; 9(1):14197. PubMed ID: 31578454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting signal-transducer-and-activator-of-transcription 3 sensitizes human cutaneous melanoma cells to BRAF inhibitor.
    Wang X; Qu H; Dong Y; Wang G; Zhen Y; Zhang L
    Cancer Biomark; 2018; 23(1):67-77. PubMed ID: 30010109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vemurafenib resistance increases melanoma invasiveness and modulates the tumor microenvironment by MMP-2 upregulation.
    Sandri S; Faião-Flores F; Tiago M; Pennacchi PC; Massaro RR; Alves-Fernandes DK; Berardinelli GN; Evangelista AF; de Lima Vazquez V; Reis RM; Maria-Engler SS
    Pharmacol Res; 2016 Sep; 111():523-533. PubMed ID: 27436149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcripts 202 and 205 of IL-6 confer resistance to Vemurafenib by reactivating the MAPK pathway in BRAF(V600E) mutant melanoma cells.
    Zhao K; Lu Y; Chen Y; Cheng J; Zhang W
    Exp Cell Res; 2020 May; 390(2):111942. PubMed ID: 32173467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma.
    Zhao B; Cheng X; Zhou X
    Melanoma Res; 2018 Dec; 28(6):521-526. PubMed ID: 30192303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Overcomes Cellular Resistance to Vemurafenib Through Dephosphorylation of AKT in BRAF-mutated Melanoma Cells.
    Luo H; Umebayashi M; Doi K; Morisaki T; Shirasawa S; Tsunoda T
    Anticancer Res; 2016 Jul; 36(7):3585-9. PubMed ID: 27354627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Localization of BRAF
    Zerfaoui M; Toraih E; Ruiz E; Errami Y; Attia AS; Krzysztof M; Abd Elmageed ZY; Kandil E
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF
    Martin S; Dudek-Peric AM; Garg AD; Roose H; Demirsoy S; Van Eygen S; Mertens F; Vangheluwe P; Vankelecom H; Agostinis P
    Autophagy; 2017 Sep; 13(9):1512-1527. PubMed ID: 28722539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib sensitizes melanoma cells to vemurafenib through ferroptosis.
    Tang F; Li S; Liu D; Chen J; Han C
    Transl Cancer Res; 2020 Mar; 9(3):1584-1593. PubMed ID: 35117506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACY-1215 accelerates vemurafenib induced cell death of BRAF-mutant melanoma cells via induction of ER stress and inhibition of ERK activation.
    Peng U; Wang Z; Pei S; Ou Y; Hu P; Liu W; Song J
    Oncol Rep; 2017 Feb; 37(2):1270-1276. PubMed ID: 28035401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.